Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators - Test2 - elhamkhani - TriplyDB

Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators

Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators

http://www.wikidata.org/entity/Q28297614

about

Novel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory?What we have learned: the impact of quality from a clinical trials perspective Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy.Radiation enteropathy--pathogenesis, treatment and prevention An update on the use and investigation of probiotics in health and disease.The NIAID Radiation Countermeasures Program business model Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation Decreasing the adverse effects of cancer therapy: an NCI Workshop on the preclinical development of radiation injury mitigators/protectors.Normal tissue protection for improving radiotherapy: Where are the Gaps?A Multi-stage Carcinogenesis Model to Investigate Caloric Restriction as a Potential Tool for Post-irradiation Mitigation of Cancer Risk.Radiation-induced afferent arteriolar endothelial-dependent dysfunction involves decreased epoxygenase metabolites Salen Mn complexes mitigate radiation injury in normal tissues.Trial Watch: Immunotherapy plus radiation therapy for oncological indications.Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?Radiation-induced brain damage, impact of Michael Robbins' work and the need for predictive biomarkers.Radiobiological modifiers in clinical radiation oncology: current reality and future potential.Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123.Trial Watch: Anticancer radioimmunotherapy.Trial Watch: Radioimmunotherapy for oncological indications.Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016.Reducing the toxicity of cancer therapy: recognizing needs, taking action.Space-relevant radiation modifies cytokine profiles, signaling proteins and Foxp3+ T cells.

P2860

Q26823881-1A448D9F-FC7B-463F-96CD-A10B4209CC37 Q27008209-DC198A12-7E3C-4442-9944-14CC60FF5BC9 Q27334040-E21B3A49-B9E6-4803-808A-0522FFAC8F83 Q28237189-880AD076-BCE0-4259-AF1D-67ADD3E7296D Q30407565-85886394-2807-40E3-B52B-A9E3F06B0F05 Q34447752-B5D1B6D1-BB35-4885-95E2-45916653116D Q35823431-20418E3A-1A5B-4B37-9EAF-8462E35713C1 Q35878951-ABCC588E-9E5C-442F-BCFB-27DA30719C7E Q36137870-F5FF87CF-554A-42BA-A0F9-360184C72ED2 Q37066432-DF9FE1AB-7BC8-4014-A2A8-002C7C16EB64 Q37071883-63077B8A-0D00-4220-B593-2E0233716D56 Q37270688-5B7A9CCC-E32F-4AE6-973E-DFDD08D71569 Q37308207-7435DCAD-95C1-4BEC-BF2A-6AF1554C459D Q38019401-3E353B8C-B3A6-429E-AAA8-142DAC04B1AB Q38213111-96442EAF-0F99-4A32-80FB-7A4923D80076 Q38294597-0BA14449-DA90-465A-A49B-25F832BAA966 Q39833861-40B9EB6C-82CF-422F-A6E7-F42718BE08FE Q42847992-A77740CD-6B63-445E-9D9A-2F4590F11391 Q43104064-6872E2CD-A5E7-44D5-97DF-0A4676DF08E0 Q45058787-C335F1F2-A853-4C36-B236-7B291E05EAAA Q51581622-02303CCB-A1AD-487F-B89C-1809701CE0B1 Q54493452-9C35703F-6E7A-4264-BE3B-72BCD792A2E6

P2860

Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators

http://www.wikidata.org/entity/Q28297614

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Decreasing the adverse effects ...... of radiation injury mitigators

@ast

Decreasing the adverse effects ...... of radiation injury mitigators

@en

Decreasing the adverse effects ...... of radiation injury mitigators

@nl

type

label

Decreasing the adverse effects ...... of radiation injury mitigators

@ast

Decreasing the adverse effects ...... of radiation injury mitigators

@en

Decreasing the adverse effects ...... of radiation injury mitigators

@nl

prefLabel

Decreasing the adverse effects ...... of radiation injury mitigators

@ast

Decreasing the adverse effects ...... of radiation injury mitigators

@en

Decreasing the adverse effects ...... of radiation injury mitigators

@nl

P1433

Q28297614-BFF6AD63-22EB-4381-881D-5537B72EC9D7

P1476

Q28297614-3E2CCB30-D229-44EE-A29F-6F1FE6732B9A

P2093

Q28297614-2BE4B153-B5BD-442C-AB21-3A387CB90909

Q28297614-2DD8E0B4-4C01-4F52-98CD-C983816EAE11

Q28297614-48E25138-68B2-4BC8-AE7F-556416372940

Q28297614-4C80749D-C9F8-4D6C-9B7E-7EEEFFDF4AE3

Q28297614-924810D0-1F3A-49E5-99FD-0F7CA7F62EEA

Q28297614-DEB72C7E-8E3E-45E3-ADC1-F322EFADAA27

Q28297614-FB15247E-CD34-4830-AB3C-631094A7423A

Q28297614-FB5C24F2-78C7-4539-9034-C3C119AB5584

P304

Q28297614-7456EDAE-A9DE-44F6-8CF2-4B293096598C

P31

Q28297614-2BFF7215-40E6-47AC-B15E-04F0A8516E1A

P3181

Q28297614-8B61E99D-1BBE-475B-AE9F-4D2B24866CD3

P356

Q28297614-536CFB97-8596-42B0-BBA2-2B546EA071C4

P407

Q28297614-C020E40B-CB59-49C2-93B6-69D11E03C6D1

P433

Q28297614-4CBAB0E9-2891-46D6-8D6C-8CCD1F6F37F4

P478

Q28297614-B8AFDD6D-E701-45DD-8964-3FF534060A04

P50

Q28297614-5CF53E8B-E08E-4FDB-BF1D-B34F0379E302

Q28297614-EDA3A02E-8894-4FAA-9279-DA1FD5D86253

P577

Q28297614-F4E345B8-7958-4CC2-B8AE-F099FE0CBBD1

P698

Q28297614-829477BD-5E6D-4646-93E3-D0E6FF146B3D

P921

Q28297614-A8F5592A-B8A7-42A5-AEDF-7DB20390934B

P3181

P356

1078-0432.CCR-10-1402

P1433

Clinical Cancer Research

P1476

Decreasing the adverse effects ...... of radiation injury mitigators

@en

P2093

Benjamin Movsas

http://www.w3.org/2001/XMLSchema#string

Bhadrasain Vikram

http://www.w3.org/2001/XMLSchema#string

C Norman Coleman

http://www.w3.org/2001/XMLSchema#string

John E Moulder

http://www.w3.org/2001/XMLSchema#string

Lisa A Kachnic

http://www.w3.org/2001/XMLSchema#string

Martin Hauer-Jensen

http://www.w3.org/2001/XMLSchema#string

Paul Okunieff

http://www.w3.org/2001/XMLSchema#string

Stephen L Brown

http://www.w3.org/2001/XMLSchema#string

P304

222-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

346411

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-10-1402

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21047979

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy